Selenium and colorectal adenoma: Results of a pooled analysis

Journal of the National Cancer Institute

Volumn 96, Issue 22, 2004, Pages 1669-1675

  Jacobs, Elizabeth T ^a,b   Jiang, Ruiyun ^a   Alberts, David S ^a   Greenberg, E Robert ^c   Gunter, Elaine W ^d   Karagas, Margaret R ^c   Lanza, Elaine ^e   Ratnasinghe, Luke ^f   Reid, Mary E ^g   Schatzkin, Arthur ^e   Smith Warner, Stephanie A ^h   Wallace, Kristin ^c   Martínez, María Elena ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c NORRIS COTTON CANCER CENTER   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^g ROSWELL PARK CANCER INSTITUTE   (United States)

^h HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SELENIUM; TRACE ELEMENT;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CANCER RISK; CLINICAL TRIAL; COLON ADENOMA; COLONOSCOPY; CONCENTRATION (PARAMETERS); CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECTUM ADENOMA; RISK REDUCTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADENOMA; ADULT; AGED; ANTICARCINOGENIC AGENTS; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; DIETARY FIBER; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SELENIUM COMPOUNDS;

EID: 9744252443     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djh310     Document Type: Article

References (33)

1. Pennington JA, Young BE. Total diet study nutritional elements, 1982-1989. J Am Diet Assoc 1991;91:179-83.
2. Kafai MR, Ganji V. Sex, age, geographical location, smoking, and alcohol consumption influence serum selenium concentrations in the USA: Third National Health and Nutrition Examination Survey, 1988-1994. J Trace Elem Med Biol 2003;17:13-8.
3. Schrauzer GN, White DA, Schneider CJ. Cancer mortality correlation studies - III: statistical associations with dietary selenium intakes. Bioinorg Chem 1977;7:23-31.
4. Samaha HS, Hamid R, el-Bayoumy K, Rao CV, Reddy BS. The role of apoptosis in the modulation of colon carcinogenesis by dietary fat and by the organoselemum compound 1,4-phenylenebis(methylene)selenocyanate. Cancer Epidemiol Biomarkers Prev 1997;6:699-704.
5. Combs GF Jr, Gray WP. Chemopreventive agents: Selenium. Pharmacol Ther 1998;79:179-92.
6. McKenzie RC, Rafferty TS, Beckett G.J. Selenium: an essential element for immune function. Immunol Today 1998;19:342-5.
7. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. [published erratum appears in JAMA 1997;277:1520.] JAMA 1996;276:1957-63.
8. Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF, Slate EH, Fischbach LA, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 2002;11:630-9.
9. Willett WC, Polk BF, Morris JS, Stampfer MJ, Pressel S, Rosner B, et al. Prediagnostic serum selenium and risk of cancer. Lancet 1983;2:130-4.
10. Clark LC, Hixson LJ, Combs GF Jr, Reid ME, Turnbull BW, Sampliner RE. Plasma selenium concentration predicts the prevalence of colorectal adenomatous polyps. Cancer Epidemiol Biomarkers Prev 1993;2:41-6.
11. Dworkin BM, Rosenthal WS, Mittelman A, Weiss L, Applebee-Brady L, Arlin Z. Selenium status and the polyp-cancer sequence: a colonoscopically controlled study. Am J Gastroenterol 1988;83:748-51.
12. Russo MW, Murray SC, Wurzelmann JI, Woosley JT, Sandler RS. Plasma selenium levels and the risk of colorectal adenomas. Nutr Cancer 1997;28: 125-9.
13. Psathakis D, Wedemeyer N, Oevermann E, Krug F, Siegers CP, Bruch HP. Blood selenium and glutathione peroxidase status in patients with colorectal cancer. Dis Colon Rectum 1998;41:328-35.
14. Fernandez-Banares F, Cabre E, Esteve M, Mingorance MD, Abad-Lacruz A, Lachica M, Gil A, et al. Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status. Am J Gastroenterol 2002;97:2103-8.
15. Ghadirian P, Maisonneuve P, Perret C, Kennedy G, Boyle P, Krewski D, et al. A case-control study of toenail selenium and cancer of the breast, colon, and prostate. Cancer Detect Prev 2000;24:305-13.
16. Early DS, Hill K, Burk R, Palmer I. Selenoprotein levels in patients with colorectal adenomas and cancer. Am J Gastroenterol 2002;97:745-8.
17. Nelson RL, Davis FG, Sutter E, Kikendall JW, Sobin LH, Milner JA, et al. Serum selenium and colonic neoplastic risk. Dis Colon Rectum 1995;38: 1306-10.
18. Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 1999;28:1-9.
19. Martinez ME, Reid ME, Guillen-Rodriguez J, Marshall JR, Sampliner R, Aickin M, et al. Design and baseline characteristics of study participants in the wheat bran fiber trial. Cancer Epidemiol Biomarkers Prev 1998;7: 813-6.
20. Schatzkin A, Lanza E, Freedman LS, Tangrea J, Cooper MR, Marshall JR, et al. The Polyp Prevention Trial I: rationale, design, recruitment, and baseline participant characteristics. Cancer Epidemiol Biomarkers Prev 1996;5:375-83.
21. Greenberg ER, Baron JA, Tosteson TD, Freeman DH, Beck GJ, Bond JH, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med 1994;331:141-7.
22. Alberts DS, Martinez ME, Roe DJ, Guillen-Rodriguez JM, Marshall JR, van Leeuwen JB, et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix colon cancer prevention physicians' network. N Engl J Med 2000;342:1156-62.
23. Wallace K, Byers T, Morris JS, Cole BF, Greenberg ER, Baron JA, et al. Prediagnostic serum selenium concentration and risk of recurrent colorectal adenoma: A nested case-control study. Cancer Epidemiol Biomarkers Prev 2003;12:464-7.
24. Gunter EW, Lewis BL, Koncikowski SM. Laboratory methods used for the Third National Health and Nutrition Examination Survey (NHANES III), 1998-1994. NHANES III Reference Manuals and Reports, Centers for Disease Control and Prevention. Hyattsville (MD); 1996. p. VII-I-1-14.
25. Olson OE, Palmer IS, Cary EE. Modification of the official fluorometric method for selenium in plants. J Assoc Off Anal Chem 1975;58:117-21.
26. Cochran WG. The combination of estimates from different experiments. Biometrics 1954;10:101-29.
27. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
28. Shamberger RJ, Tytko SA, Willis CE. Antioxidants and cancer. Part VI. Selenium and age-adjusted human cancer mortality. Arch Environ Health 1976;31:231-5.
29. Duffield AJ, Thomson CD, Hill KE, Williams S. An estimation of selenium requirements for New Zealanders. Am J Clin Nutr 1999;70:896-903.
30. Ip C, Dong Y, Ganther HE. New concepts in selenium chemoprevention. Cancer Metastasis Rev 2002;21:281-9.
31. Fleming J, Ghose A, Harrison PR. Molecular mechanisms of cancer prevention by selenium compounds. Nutr Cancer 2001;40:42-9.
32. Duffield-Lillico AJ, Slate EH, Reid ME, Turnbull BW, Wilkins PA, Combs GF, et al. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J Natl Cancer Inst 2003;95:1477-81.
33. Hu G, Cassano PA. Antioxidant nutrients and pulmonary function: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Epidemiol 2000;151:975-81.